Limination: a revised national malaria strategy 2010?015. Beijing; 2009:2?. two. Ministry of Well being, People’s Republic of China: Malaria elimination action plan 2010?020. Beijing (in Chinese). Beijing; 2009:1?. 2010. 3. Cotter C, Sturrock HJW, Hsiang MS, Liu J, Phillips AA, Hwang J, Gueye CS, Fullman N, Gosling RD, Feachem RGA: The altering epidemiology of malaria elimination: new strategies for new challenges. Lancet 2013, 382:900?11. 4. World Overall health Organization: Recommendations for the remedy of malaria. Geneva; 2006:1?six. 5. Yang H, Xu JW, Wang WR: The evaluation of implementation and effectiveness of etiological handle measure of malaria at present in Yuanjiang Basin, Yunnan (in Chinese, abstract in English). Endemic Diseases Bulletin 1999, 14:56?1. six. Rieckmann KH, Davis DR, Hutton DC: Plasmodium vivax resistance to chloroquine? Lancet 1989, 2:1183?184. 7. Phyo AP, Lwin KM, Price RN, Ashley EA, Russell B, Sriprawat K, Lindegardh N, Singhasivanon P, White NJ, Nosten F: Dihydroartemisinin-piperaquine versus chloroquine in the therapy of Plasmodium vivax malaria in Thailand: a randomized controlled trial. Clin Infect Dis 2011, 53:977?84. eight. Tun T, Tint HS, Lin K, Kyaw TT, Myint MK, Khaing W, Tun ZW: Efficacy of oral single dose therapy with artemisinin-naphthoquine phosphate in uncomplicated falciparum malaria. Acta Trop 2009, 111:275?78. 9. Wang JY, Shan CQ, Fu DD, Sun ZW, Ding DB: Efficacy of naphthoquine, artemisinine and also a mixture in the two drugs in the treatment of falciparum malaria (in Chinese). Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2003, 21:131?33. 10. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP: Effectiveness of 5 artemisinin combination regimens with or without having primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 2010, ten:673?81. 11. Hombhanje FW, Linge D, Saweri A, Cynthia K: Artemisinin-naphthoquine mixture (ARCOTM) therapy for uncomplicated falciparum malaria inLiu et al. Malaria Journal 2013, 12:409 http://malariajournal/content/12/1/Page 7 of12. 13.14.15.16.17. 18. 19.20.21.adults of Papua New Guinea: a preliminary report on security and efficacy. Malar J 2009, 8:196. Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN: Artemisinin combination therapy for vivax malaria. Lancet Infect Dis 2010, ten:405?16. Li XL, Che LG, Li CF: Observation on the effectiveness of naphthoquine phosphate tablets on patients with vivax malaria and falciparum malaria (in Chinese).1234616-13-7 Data Sheet Chin Trop Med 2003, three:608?09.1083246-26-7 manufacturer Ratcliff A, Siswantoro H, Kenangalem E, Maristela R: Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.PMID:33720392 Lancet 2007, 369:757?65. Hwang J, Alemayehu BH, Reithinger R, Tekleyohannes SG, Teshi T, Birhanu SG, Demeke L, Hoos D, Melaku Z, Kassa M, Jima D, Malone J, Nettey H, Green M, Poe A, Akinyi S, Udhayakumar V, Kachur P, Filler S: In Vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia. PLoS One particular 2013, eight:e63433. Yang H, Yang Y, Yang P, Li L, Gao B, Zhang Z, Yang Z: Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981?006. Acta Trop 2008, 108:44?9. Wang D, Bakhai: Clinical trials: a sensible guide to design and style, evaluation and reporting. London: Remedica; 2006:81?0. Shan CQ, liu GY, Jiao XQ: Observation on efficacy of naphthoquine against vivax malaria (in Chinese). C.